ECDC Forward Look Risk Assessment: Seasonal influenza 2010–2011 in Europe
The 2010/11 seasonal influenza epidemics in Europe are dominated so far by the A(H1N1)2009 viruses which emerged in the 2009 pandemic, although these are now considered seasonal viruses. This is an interim risk assessment and will be up-dated at intervals as more data and analyses emerge.
ECDC Forward look risk assessment (Update 28 October 2010): Likely scenarios and uncertainties in the 2010/2011 influenza season in Europe and beyond
Likely scenarios and uncertainties in the 2010/2011 influenza season in Europe and beyond.
Meeting report: Understanding the behavioural aspects and the role of health communication in mitigating the impact of seasonal influenza
The meeting report covers health communication strategies that could be undertaken to better promote influenza prevention measures and the healthcare professionals’ role in the uptake of seasonal influenza vaccination. In January 2011, ECDC organised a workshop to exchange countries’ experiences and discuss recent research on behavioural aspects of the population response to preventive measures regarding influenza. “Understanding the behavioural aspects and the role of health communication in mitigating the impact of seasonal influenza” was a two-day meeting held in Stockholm and brought together behavioural scientists, experts in communication and public health professionals.
Annual epidemiological report 2011 [2009 data]
Reporting on 2009 surveillance data and 2010 epidemic intelligence data
- Antibiotic/Antimicrobial resistance (AMR)
- avian influenza in humans
- avian influenza virus
- food- and waterborne disease
- healthcare-associated infections
- HIV infection
- respiratory disease
- seasonal influenza
- sexually transmitted infection
- vaccine preventable disease
- viral hepatitis
ECDC rapid risk assessment: Reassortment seasonal influenza virus and swine influenza virus
New strain of swine influenza identified in two workers on a pig farm in Canada. Swine influenza (SI) is an acute viral infection of the respiratory tract in pigs. Subclinical infections are also common. The mortality is low and recovery usually occurs within 7-10 days.
Risk assessment: Seasonal influenza 2011–2012 in Europe (EU/EEA countries)
ECDC produces an annual risk assessment for the seasonal influenza epidemics in Europe. This is following both a recommendation in the report on the handling of the 2009 pandemic adopted by the World Health Assembly in May 2011 and the model developed by ECDC during that pandemic. The first EU seasonal influenza risk assessment was published in January 2011, following the start of the influenza season in late November 2010. In 2012, the season started later than in most years, with the first five countries exceeding their epidemic threshold in week 3/2012.
Seasonal influenza - Annual Epidemiological Report for 2014-15 season
Influenza activity started in week 50/2014 and lasted until week 20/2015, as in the previous season. Compared with the previous season, nine EU/EEA countries reported higher peak ILI rates in primary care. In almost all countries, the season was dominated by influenza A(H3N2) viruses.
Narcolepsy in association with pandemic influenza vaccination – a multi-country European epidemiological investigation
This report summarises the results from two epidemiological studies conducted by the Vaccine Adverse Event Surveillance and Communication (VAESCO) Consortium undertaken in eight European Union (EU)/European Economic Area (EEA) countries in order to investigate a possible association between an unexpected increase in narcolepsy cases following the use of influenza A(H1N1)pdm09 vaccines. Narcolepsy is an underdiagnosed disease of widely unknown etiology.
Technical report In Brief: Narcolepsy in association with pandemic influenza vaccination
This report summarises the results from two epidemiological studies to investigate a possible association between an unexpected increase in narcolepsy cases following the use of the influenza A(H1N1)pdm09 vaccines. The studies were conducted by the Vaccine Adverse Event Surveillance and Communication (VAESCO) Consortium under the auspices of ECDC and undertaken in Denmark, Finland, France, Italy, the Netherlands, Norway, Sweden and the United Kingdom. This Technical Report In Brief accompanies the full Report ‘Narcolepsy in association with pandemic influenza vaccination- A multi-country European epidemiological investigation’.
Seasonal influenza vaccination of children and pregnant women (ECDC guidance, published 2012)
The aim of this guidance document is to provide EU/EEA Member States and EU bodies with relevant information to make an informed decision on routine vaccination of healthy children and pregnant women with seasonal influenza vaccine. The options presented in this document are based on a systematic review of the literature and the opinions of a group of independent experts.